©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 112169
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.112169
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.112169
Figure 1 Serum inflammatory biomarkers.
A: Procalcitonin comparison (good vs poor prognosis groups); B: Inter-group comparison of C-reactive protein; C: Interleukin-6 measurements; D: Interleukin-10 disparities; E: Tumor necrosis factor-alpha differences. bP < 0.01 vs good prognosis group. PCT: Procalcitonin; CRP: C-reactive protein; IL: Interleukin; TNF-α: Tumor necrosis factor-alpha.
Figure 2 Receiver operating characteristic analysis of serum inflammatory biomarkers’ predictive value for outcomes in sepsis-induced gastrointestinal dysfunction.
PCT: Procalcitonin; CRP: C-reactive protein; IL: Interleukin; TNF-α: Tumor necrosis factor-alpha.
- Citation: Liu YH, Chen QY, Dai FY, Chen XY. Serum inflammatory biomarkers can predict clinical outcomes in patients with sepsis-associated gastrointestinal dysfunction. World J Gastrointest Surg 2026; 18(2): 112169
- URL: https://www.wjgnet.com/1948-9366/full/v18/i2/112169.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i2.112169
